Capstone Investment Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-21,090
Closed -$50K 868
2021
Q1
$50K Sell
21,090
-106,080
-83% -$251K ﹤0.01% 528
2020
Q4
$224K Buy
+127,170
New +$224K ﹤0.01% 388